Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXCP.L Regulatory News (MXCP)

  • There is currently no data for MXCP

Issue of Equity

15 Jan 2015 12:47

RNS Number : 2760C
MXC Capital PLC
15 January 2015
 



MXC Capital plc

("MXC" or the "Company")

Issue of Equity

 

As announced on 18 December 2014 the Company agreed to grant 10,714,000 new ordinary shares to Alex Sandberg in satisfaction of a three year consultancy agreement for the provision of corporate communications and strategic advice (the "Consultancy Shares"). The Company has the right to repurchase the Consultancy Shares under certain circumstances if the consultancy agreement is terminated. The first tranche of 5,347,000 shares were admitted to trading on AIM on 24 December 2014.

The Company has now issued the final tranche of 5,347,000 shares.

Application has been made to the London Stock Exchange for the final tranche of Consultancy Shares to be admitted to trading on AIM and it is expected that admission will become effective and that dealings will commence on 16 January 2015.

Following Admission of the final tranche of Consultancy Shares, the total number of voting rights in the Company will be 1,965,350,992 which figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

MXC Capital plc

Marc Young

+44(0)20 7965 8149

Zeus Capital Limited (Nominated adviser and broker)

John Depasquale/John Treacy

+44 (0)20 7533 7727

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBAMTTMBIBBFA
Date   Source Headline
3rd Dec 20084:52 pmRNSHolding(s) in Company
1st Dec 20087:00 amRNSTransaction in Own Shares
25th Nov 20081:11 pmRNSShare repurchase programme
19th Nov 20087:00 amRNSFinal Results
10th Nov 20084:15 pmRNSNotice of Results
17th Sep 20087:00 amRNSTrading Update
11th Aug 20084:07 pmRNSHolding(s) in Company
4th Aug 20085:10 pmRNSHolding(s) in Company
31st Jul 20087:00 amRNSContract Win
29th Jul 20087:00 amRNSLoan Agreement
29th Jul 20087:00 amRNSAcquisition & Loan Agreement
3rd Jul 20084:47 pmRNSHolding(s) in Company
5th Jun 200810:12 amRNSHolding(s) in Company
28th May 20081:27 pmRNSHolding(s) in Company
19th May 20087:00 amRNSInterim Results
19th May 20087:00 amRNSIFRS Restatement Report
14th May 20086:10 pmRNSHolding(s) in Company
9th May 200812:43 pmRNSNotice of Results
28th Apr 200810:39 amRNSResult of EGM
14th Apr 200810:41 amRNSHolding(s) in Company
4th Apr 20081:41 pmRNSNotice of EGM
4th Mar 20084:33 pmRNSHolding(s) in Company
29th Feb 200810:46 amRNSResult of AGM
29th Feb 20087:01 amRNSTrading Update
25th Feb 20084:54 pmRNSHolding(s) in Company
25th Feb 20084:52 pmRNSIssue of Equity
6th Feb 200812:15 pmRNSNotice of AGM
4th Feb 200811:37 amRNSHolding(s) in Company
7th Jan 20087:01 amRNSContract with O2
19th Dec 20074:22 pmRNSHolding(s) in Company
29th Nov 20077:00 amRNSIssue of Equity
22nd Nov 20077:01 amRNSFinal Results
8th Nov 20074:33 pmRNSHolding(s) in Company
1st Nov 20077:02 amRNSProteus Agreement and Launch
31st Oct 20074:08 pmRNSNotice of Results
26th Oct 20073:15 pmRNSHolding(s) in Company
9th Oct 200712:35 pmRNSHolding(s) in Company
8th Oct 20077:01 amRNSLaunch of MultiSend
1st Oct 20077:02 amRNSContract Win
19th Sep 20072:07 pmRNSDirector/PDMR Shareholding
22nd Aug 20077:00 amRNSTrading Update
17th Aug 200710:42 amRNSAIM Rule 26
16th Aug 20075:57 pmRNSHolding(s) in Company
16th Aug 20079:13 amRNSWebsite Compliance
9th Jul 20077:00 amRNSManagement Incentive Plan
12th Jun 20077:03 amRNSAgreement with Rightmove
23rd May 20077:01 amRNSInterim Results
4th May 200710:00 amRNSNotice of Results
7th Mar 20079:01 amRNSHolding(s) in Company
6th Mar 20075:03 pmRNSCompletion of Demerger

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.